GB0328243D0 - Methods - Google Patents

Methods

Info

Publication number
GB0328243D0
GB0328243D0 GBGB0328243.1A GB0328243A GB0328243D0 GB 0328243 D0 GB0328243 D0 GB 0328243D0 GB 0328243 A GB0328243 A GB 0328243A GB 0328243 D0 GB0328243 D0 GB 0328243D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0328243.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0328243.1A priority Critical patent/GB0328243D0/en
Publication of GB0328243D0 publication Critical patent/GB0328243D0/en
Priority to TW093136325A priority patent/TWI347945B/zh
Priority to US10/581,143 priority patent/US7790883B2/en
Priority to AU2004296241A priority patent/AU2004296241B2/en
Priority to DE602004027840T priority patent/DE602004027840D1/de
Priority to MYPI20044990A priority patent/MY143761A/en
Priority to AT04801262T priority patent/ATE471941T1/de
Priority to EP04801262A priority patent/EP1711505B1/en
Priority to KR1020067010850A priority patent/KR101170188B1/ko
Priority to CA002546719A priority patent/CA2546719A1/en
Priority to SG200809048-2A priority patent/SG149005A1/en
Priority to NZ583012A priority patent/NZ583012A/en
Priority to JP2006542009A priority patent/JP4808629B2/ja
Priority to ES04801262T priority patent/ES2345660T3/es
Priority to CN2004800414459A priority patent/CN1914213B/zh
Priority to PCT/GB2004/005072 priority patent/WO2005056563A2/en
Priority to NZ547685A priority patent/NZ547685A/en
Priority to BRPI0417300-7A priority patent/BRPI0417300A/pt
Priority to ARP040104522A priority patent/AR046750A1/es
Priority to UY28651A priority patent/UY28651A1/es
Priority to IL175743A priority patent/IL175743A/en
Priority to ZA200604491A priority patent/ZA200604491B/en
Priority to NO20063111A priority patent/NO20063111L/no
Priority to US12/121,228 priority patent/US20090043097A1/en
Priority to US12/638,415 priority patent/US20100217000A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
GBGB0328243.1A 2003-12-05 2003-12-05 Methods Ceased GB0328243D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GBGB0328243.1A GB0328243D0 (en) 2003-12-05 2003-12-05 Methods
TW093136325A TWI347945B (en) 2003-12-05 2004-11-25 Process for the preparation of thiazolopyrimidines
BRPI0417300-7A BRPI0417300A (pt) 2003-12-05 2004-12-02 métodos para a preparação de compostos de tiazolpirimidina
JP2006542009A JP4808629B2 (ja) 2003-12-05 2004-12-02 チアゾロピリミジンの製造方法
ES04801262T ES2345660T3 (es) 2003-12-05 2004-12-02 Procedimiento para la preparacion de tiazolopirimidinas.
DE602004027840T DE602004027840D1 (de) 2003-12-05 2004-12-02 Verfahren zur herstellung von thiazolopyrimidinen
MYPI20044990A MY143761A (en) 2003-12-05 2004-12-02 Process for the preparation of thiazolopyrimidines
AT04801262T ATE471941T1 (de) 2003-12-05 2004-12-02 Verfahren zur herstellung von thiazolopyrimidinen
EP04801262A EP1711505B1 (en) 2003-12-05 2004-12-02 Process for the preparation of thiazolopyrimidines
KR1020067010850A KR101170188B1 (ko) 2003-12-05 2004-12-02 티아졸로피리미딘의 제조 방법
CA002546719A CA2546719A1 (en) 2003-12-05 2004-12-02 Process for the preparation of thiazolopyrimidines
SG200809048-2A SG149005A1 (en) 2003-12-05 2004-12-02 Process for the preparation of thiazolopyrimidines
NZ583012A NZ583012A (en) 2003-12-05 2004-12-02 Process for the preparation of thiazolopyrimidines
US10/581,143 US7790883B2 (en) 2003-12-05 2004-12-02 Process for the preparation of thiazolopyrimidines
AU2004296241A AU2004296241B2 (en) 2003-12-05 2004-12-02 Process for the preparation of thiazolopyrimidines
CN2004800414459A CN1914213B (zh) 2003-12-05 2004-12-02 噻唑并嘧啶的制备方法
PCT/GB2004/005072 WO2005056563A2 (en) 2003-12-05 2004-12-02 Process for the preparation of thiazolopyrimidines
NZ547685A NZ547685A (en) 2003-12-05 2004-12-02 Process for the preparation of thiazolopyrimidines
UY28651A UY28651A1 (es) 2003-12-05 2004-12-03 Metodos
ARP040104522A AR046750A1 (es) 2003-12-05 2004-12-03 Proceso de preparacion de tiazolpirimidinas,compuestos intermediarios utilizados en dicho proceso,y tiazolpirimidinas obtenidas
IL175743A IL175743A (en) 2003-12-05 2006-05-18 Process for the preparation of thiazolopyrimidines
ZA200604491A ZA200604491B (en) 2003-12-05 2006-06-01 Process for the preparation of thiazolopyrimidines
NO20063111A NO20063111L (no) 2003-12-05 2006-07-04 Fremgangsmate for fremstilling av tiazolpyrimidiner
US12/121,228 US20090043097A1 (en) 2003-12-05 2008-05-15 Methods
US12/638,415 US20100217000A1 (en) 2003-12-05 2009-12-15 Process for the Preparation of Thiazolopyrimidines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0328243.1A GB0328243D0 (en) 2003-12-05 2003-12-05 Methods

Publications (1)

Publication Number Publication Date
GB0328243D0 true GB0328243D0 (en) 2004-01-07

Family

ID=29764654

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0328243.1A Ceased GB0328243D0 (en) 2003-12-05 2003-12-05 Methods

Country Status (22)

Country Link
US (3) US7790883B2 (enExample)
EP (1) EP1711505B1 (enExample)
JP (1) JP4808629B2 (enExample)
KR (1) KR101170188B1 (enExample)
CN (1) CN1914213B (enExample)
AR (1) AR046750A1 (enExample)
AT (1) ATE471941T1 (enExample)
AU (1) AU2004296241B2 (enExample)
BR (1) BRPI0417300A (enExample)
CA (1) CA2546719A1 (enExample)
DE (1) DE602004027840D1 (enExample)
ES (1) ES2345660T3 (enExample)
GB (1) GB0328243D0 (enExample)
IL (1) IL175743A (enExample)
MY (1) MY143761A (enExample)
NO (1) NO20063111L (enExample)
NZ (2) NZ583012A (enExample)
SG (1) SG149005A1 (enExample)
TW (1) TWI347945B (enExample)
UY (1) UY28651A1 (enExample)
WO (1) WO2005056563A2 (enExample)
ZA (1) ZA200604491B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903544D0 (sv) 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
GB2359551A (en) 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
SE0102716D0 (sv) * 2001-08-14 2001-08-14 Astrazeneca Ab Novel compounds
GB0221828D0 (en) 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0221829D0 (en) * 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0328243D0 (en) 2003-12-05 2004-01-07 Astrazeneca Ab Methods
JP6463366B2 (ja) 2013-10-10 2019-01-30 イースタン バージニア メディカル スクール １２−リポキシゲナーゼ阻害物質としての４−（（２−ヒドロキシ−３−メトキシベンジル）アミノ）ベンゼンスルホンアミド誘導体
GB201807898D0 (en) * 2018-05-15 2018-06-27 Kancera Ab New processes and products with increased chiral purity

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2924472A (en) * 1957-06-27 1960-02-09 Gen Motors Corp Pipe joint seal
GB1009477A (en) 1962-02-13 1965-11-10 Smith Kline French Lab Novel process for preparing heterocyclic compounds
US3182062A (en) * 1962-02-28 1965-05-04 Smith Kline French Lab Synthesis of quinoxalines and analogues thereof
US3318900A (en) * 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
BE668603A (enExample) * 1964-08-20
DE2331223C2 (de) 1972-06-19 1984-11-22 Kohjin Co., Ltd., Tokio / Tokyo S-substituierte-2-Thioadenosine, deren 5'-Monophosphate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
JPS5188994A (en) 1975-02-04 1976-08-04 Shinkijichikan 88 aminoadeninjudotainoseizoho
US4120521A (en) * 1975-08-28 1978-10-17 Rieber & Son Plastic-Industri A/S Combined mould element and sealing ring
EG12406A (en) * 1976-08-12 1979-03-31 Janssen Pharmaceutica Nv Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
GB1600293A (en) * 1977-02-04 1981-10-14 British Oceanics Ltd Sealing arrangements
US4188040A (en) * 1977-04-06 1980-02-12 Firma WOCO Franz-Josef Wolf & Co. Sealing ring
DE2726959A1 (de) * 1977-06-15 1979-01-18 Arlt Christian Dichteinsatz zum dichten verbinden von zwei rohren
FR2421899A1 (fr) * 1978-01-16 1979-11-02 Roussel Uclaf Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits
US4410528A (en) * 1980-05-16 1983-10-18 Kyowa Hakko Kogyo Co., Ltd. Hypotensive piperidine derivatives
DE3219522A1 (de) * 1981-10-28 1983-12-01 Denso-Chemie Wedekind Kg, 5090 Leverkusen Steckmuffendichtung fuer rohre
FR2547888B1 (fr) * 1983-06-22 1985-12-13 Sabla Sa Bague d'etancheite a implants pour tuyaux a emboitement
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
SE8800348L (sv) * 1988-02-03 1989-08-04 Forsheda Ab Taetningsring och verktyg foer framstaellning daerav
FR2659656B1 (fr) 1990-03-15 1994-09-09 Sanofi Sa Derives de pyrimidinedione-2,4 et medicaments les contenant.
DE4119767A1 (de) 1991-06-15 1992-12-17 Dresden Arzneimittel Verfahren zur herstellung von (pyrimid-2-yl-thio- bzw. seleno)-essigsaeurederivaten
US5169161A (en) * 1991-09-19 1992-12-08 Hail Mary Rubber Co., Inc. Symmetrical gasket for pipe joints
DE4134089C2 (de) * 1991-10-15 1994-10-13 Dueker Eisenwerk Schubgesicherte Muffenverbindung
DE4229609C2 (de) * 1992-09-04 2003-05-08 Forsheda Stefa Gmbh Abdichtung zwischen zwei ineinandersteckbaren Teilen
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
EP0778277B1 (en) 1995-12-08 2003-06-25 Pfizer Inc. Substituted heterocyclic derivatives as CRF antagonists
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
SE515033C2 (sv) * 1995-12-27 2001-06-05 Forsheda Ab Tätningsanordning
PL194689B1 (pl) 1996-02-13 2007-06-29 Astrazeneca Uk Ltd Pochodne chinazoliny, ich kompozycje farmaceutyczne oraz ich zastosowania
EP0885198B1 (en) 1996-03-05 2001-12-19 AstraZeneca AB 4-anilinoquinazoline derivatives
WO1997040035A1 (en) 1996-04-19 1997-10-30 Neurosearch A/S 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
BR9711970A (pt) 1996-08-28 1999-08-24 Pfizer Derivados 6,5-substitu¡do-heterobic¡clicos
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
AU5522498A (en) 1996-12-13 1998-07-03 Merck & Co., Inc. Substituted aryl piperazines as modulators of chemokine receptor activity
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
JP2002510327A (ja) 1997-07-25 2002-04-02 メルク エンド カンパニー インコーポレーテッド 環状アミンケモカイン受容体活性調節剤
AR013669A1 (es) 1997-10-07 2001-01-10 Smithkline Beecham Corp Compuestos y metodos
KR100613634B1 (ko) * 1997-11-28 2006-08-18 다이닛본 스미토모 세이야꾸 가부시끼가이샤 신규한 복소환 화합물
DK1049689T3 (da) 1998-01-19 2002-07-22 Pfizer 4-(2-keto-1-benzimidazolinyl)piperidinderivater som ORL1-receptoragonister
CN1166665C (zh) * 1998-03-19 2004-09-15 日本农药株式会社 芳基哌啶衍生物及其用途
WO1999051608A1 (en) 1998-04-03 1999-10-14 Du Pont Pharmaceuticals Company THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
MA26659A1 (fr) 1998-08-06 2004-12-20 Pfizer Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
SE9802729D0 (sv) 1998-08-13 1998-08-13 Astra Pharma Prod Novel Compounds
US5988695A (en) * 1998-08-26 1999-11-23 S&B Technical Products, Inc. Pipe gasket with embedded ring
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
AU770551B2 (en) 1998-12-28 2004-02-26 4-Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
WO2000045800A2 (en) 1999-02-02 2000-08-10 K.U. Leuven Research & Development Immunosurpressive effects of pteridine derivatives
US6248755B1 (en) 1999-04-06 2001-06-19 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6142484A (en) * 1999-04-15 2000-11-07 Vassallo Research & Development Corporation Composite multi-pressure gasket
US6432981B1 (en) * 1999-06-11 2002-08-13 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
US6340681B1 (en) 1999-07-16 2002-01-22 Pfizer Inc 2-benzimidazolylamine compounds as ORL-1-receptor agonists
CA2393896A1 (en) 1999-09-15 2001-03-22 Warner-Lambert Company Pteridinones as kinase inhibitors
SE9903544D0 (sv) 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
PE20010628A1 (es) 1999-10-01 2001-06-18 Takeda Chemical Industries Ltd Compuestos de amina ciclica, su produccion y su uso
EP1122257B1 (en) 2000-01-05 2005-10-12 Pfizer Inc. Benzimidazole compounds as ORL1-receptor agonists
GB2359078A (en) * 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB2359081A (en) * 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active thiazolopyrimidines
GB2359079A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
DE60101372T2 (de) 2000-02-11 2004-10-14 Astrazeneca Ab Pyrimidinverbindungen und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
GB2359551A (en) * 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB0005642D0 (en) 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds
AU4274401A (en) * 2000-03-24 2001-10-03 Meiji Seika Kaisha Diphenylalkylamine derivatives useful as opioid delta receptor agonists
EP1289952A1 (en) 2000-05-31 2003-03-12 AstraZeneca AB Indole derivatives with vascular damaging activity
CN1255391C (zh) 2000-07-07 2006-05-10 安吉奥金尼药品有限公司 作为血管破坏剂的colchinol衍生物
WO2002008213A1 (en) 2000-07-07 2002-01-31 Angiogene Pharmaceuticals Limited Colchinol derivatives as angiogenesis inhibitors
SE0003828D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Novel compounds
SE0004110L (sv) * 2000-11-10 2002-05-11 Forsheda Ab Tätningsring
SE0101322D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab Novel compounds
SE0102716D0 (sv) * 2001-08-14 2001-08-14 Astrazeneca Ab Novel compounds
GB0221829D0 (en) * 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0221828D0 (en) * 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
JP2007507494A (ja) 2003-10-07 2007-03-29 アストラゼネカ・アクチエボラーグ ケモカイン受容体アンタゴニストとりわけＣＸ３ＣＲ１として有用な新規な２−置換４−アミノ−チアゾロ［４，５−ｄ］ピリミジン
GB0328243D0 (en) 2003-12-05 2004-01-07 Astrazeneca Ab Methods
WO2005082865A1 (ja) 2004-02-27 2005-09-09 Astellas Pharma Inc. 縮合二環性ピリミジン誘導体
WO2006064228A2 (en) 2004-12-17 2006-06-22 Astrazeneca Ab Thiazolopyramidine compounds for the modulation of chemokine receptor activity

Also Published As

Publication number Publication date
ATE471941T1 (de) 2010-07-15
US20090043097A1 (en) 2009-02-12
BRPI0417300A (pt) 2007-03-06
EP1711505A2 (en) 2006-10-18
EP1711505B1 (en) 2010-06-23
IL175743A (en) 2011-10-31
KR101170188B1 (ko) 2012-07-31
ES2345660T3 (es) 2010-09-29
JP2007513131A (ja) 2007-05-24
CN1914213B (zh) 2011-05-11
CA2546719A1 (en) 2005-06-23
NZ547685A (en) 2010-02-26
TW200524945A (en) 2005-08-01
AR046750A1 (es) 2005-12-21
CN1914213A (zh) 2007-02-14
US20070282103A1 (en) 2007-12-06
NO20063111L (no) 2006-09-05
US20100217000A1 (en) 2010-08-26
US7790883B2 (en) 2010-09-07
WO2005056563A3 (en) 2005-08-25
WO2005056563A2 (en) 2005-06-23
AU2004296241A1 (en) 2005-06-23
SG149005A1 (en) 2009-01-29
KR20060118525A (ko) 2006-11-23
ZA200604491B (en) 2007-10-31
MY143761A (en) 2011-07-15
TWI347945B (en) 2011-09-01
DE602004027840D1 (de) 2010-08-05
NZ583012A (en) 2011-08-26
UY28651A1 (es) 2005-07-29
AU2004296241B2 (en) 2009-01-22
JP4808629B2 (ja) 2011-11-02
IL175743A0 (en) 2006-09-05

Similar Documents

Publication Publication Date Title
GB0326439D0 (en) Methods
EP1615948A4 (en) IMMUNOLOGICAL AMPLIFICATION
EP1635758A4 (en) ORTHODYNAMIC REEDUCATION DEVICE
DE502004011703D1 (en) N-heterocyclyl-phenylsubstituierte cyclische ketoenole
DE602004012071D1 (en) T-hilfe
DE602004020356D1 (en) Phenoxyessigsäurederivate
DE602004030538D1 (en) Präzisionssubstratlagerbehälter
EP1629178A4 (en) ANCHOR BOLT
DE502004009243D1 (en) Spirocyclische cyclohexan-derivate
DE502004003476D1 (en) Standfuss
DE602004027010D1 (en) Thermotherapiehülle
DE502004006683D1 (en) Injection-locked-oscillator-schaltkreis
DE502004011852D1 (en) Nspritzventil
DE60333037D1 (en) Laser-radar
DE502004004146D1 (en) Pyrazolverbindungen
DE112004002769D2 (en) Schienengeführtes transportsystem
DK1665437T3 (en) Reformeringsmodul
DE502004011343D1 (en) Rotorspinnmaschine
DE602004012262D1 (en) Benzimidazolonverbindung
DE602004020525D1 (en) Imidazolderivate
DE502004012153D1 (en) Rotorspinnmaschine
GB0328243D0 (en) Methods
DE10394343D2 (en) Berührungslose biometrische erkennung
GB0327909D0 (en) Methods
DE602004009041D1 (en) Hydroxytetrahydronaphthalenylharnstoffderivate

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)